Close Menu

NEW YORK (GenomeWeb) – Biocept reported Monday after the close of the market a year-over-year increase in second quarter revenues and commercial testing business volume, but also a higher net loss compared to the previous year.

Separately today, the firm announced a new collaboration with the University of California, Irvine to evaluate its liquid biopsy platform in guiding treatment for metastatic cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.